БЛОГ

Archive for the ‘health’ category: Page 318

Jul 28, 2017

Two Babies Have Been Cancer-Free After Receiving Treatment Created With Gene Editing

Posted by in categories: bioengineering, biotech/medical, health

Cancer continues to be one of the major diseases that plagues humanity. Around the world, approximately 1 in 6 deaths is due to cancer, according to the World Health Organisation (WHO).

The prevalence of cancer is due, in part, to the absence of a universal cure for all forms of the disease. While various treatments are available, each type of cancer generally requires specific treatment.

A new method developed by doctors at the Great Ormond Street Hospital in London presents a hopeful solution. The team has successfully tested their method on two infants with an aggressive form of leukaemia.

Continue reading “Two Babies Have Been Cancer-Free After Receiving Treatment Created With Gene Editing” »

Jul 28, 2017

What Will Happen if You Eat 2 Bananas a Day

Posted by in categories: food, health

For copyright matters please contact us at: [email protected]

Healthy food isn’t always tasty. But with regards to bananas, this isn’t the case. Which is why it’s doubly pleasing to learn that they not only bring satisfaction to your taste buds but also a great many benefits to your health.
We at Bright Side have gathered together all the evidence showing why eating just two bananas a day can seriously improve your health.

Continue reading “What Will Happen if You Eat 2 Bananas a Day” »

Jul 20, 2017

Building the Safe Genes Toolkit

Posted by in categories: bioengineering, biotech/medical, genetics, health, security

DARPA created the Safe Genes program to gain a fundamental understanding of how gene editing technologies function; devise means to safely, responsibly, and predictably harness them for beneficial ends; and address potential health and security concerns related to their accidental or intentional misuse. Today, DARPA announced awards to seven teams that will pursue that mission, led by: The Broad Institute of MIT and Harvard; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology; North Carolina State University; University of California, Berkeley; and University of California, Riverside. DARPA plans to invest $65 million in Safe Genes over the next four years as these teams work to collect empirical data and develop a suite of versatile tools that can be applied independently or in combination to support bio-innovation and combat bio-threats.

Gene editing technologies have captured increasing attention from healthcare professionals, policymakers, and community leaders in recent years for their potential to selectively disable cancerous cells in the body, control populations of disease-spreading mosquitos, and defend native flora and fauna against invasive species, among other uses. The potential national security applications and implications of these technologies are equally profound, including protection of troops against infectious disease, mitigation of threats posed by irresponsible or nefarious use of biological technologies, and enhanced development of new resources derived from synthetic biology, such as novel chemicals, materials, and coatings with useful, unique properties.

Achieving such ambitious goals, however, will require more complete knowledge about how gene editors, and derivative technologies including gene drives, function at various physical and temporal scales under different environmental conditions, across multiple generations of an organism. In parallel, demonstrating the ability to precisely control gene edits, turning them on and off under certain conditions or even reversing their effects entirely, will be paramount to translation of these tools to practical applications. By establishing empirical foundations and removing lingering unknowns through laboratory-based demonstrations, the Safe Genes teams will work to substantially minimize the risks inherent in such powerful tools.

Read more

Jul 18, 2017

Scientists Have Reversed Brain Damage in a 2-Year-Old Girl Who Drowned in a Swimming Pool

Posted by in categories: biotech/medical, health, neuroscience

Researchers in the US have reported what they believe is a first-of-its-kind reversal of brain damage, after treating a drowned and resuscitated toddler with a combination of oxygen therapies.

The little girl, whose heart didn’t beat on her own for 2 hours after drowning, showed deep grey matter injury and cerebral atrophy with grey and white matter loss after the incident, and could no longer speak, walk, or respond to voices – but would uncontrollably squirm around and shake her head.

Continue reading “Scientists Have Reversed Brain Damage in a 2-Year-Old Girl Who Drowned in a Swimming Pool” »

Jul 17, 2017

Breathable electronic skin patch developed for continuous long-term use

Posted by in categories: electronics, health

Scientists have developed an electronic sensor that is hypoallergenic, breathable and can be worn constantly for a week, enabling continuous, unobtrusive health monitoring.

The patch, developed by scientists at the University of Tokyo, is, according to its creators, so thin and light that the majority of users will forget they are even wearing it – a far cry from many of the weighty or uncomfortable health monitoring solutions currently available.

Designed to withstand repeated and continuous bending and stretching, the patch can be worn during a host of day-to-day activities, including sports. As a result its creators believe it could be used not only in healthcare settings, but also to monitor professional athletes.

Continue reading “Breathable electronic skin patch developed for continuous long-term use” »

Jul 15, 2017

Alibaba, Tencent see AI as solution to China’s acute shortage of doctors

Posted by in categories: biotech/medical, health, robotics/AI

The world’s most populous nation suffers from a shortage of medical practitioners, with the World Health Organisation estimating there are only 1.5 physicians available for every 1,000 people, compared with 2.4 in the US and 2.8 in the UK. That has led to deteriorating work conditions for doctors and radiologists who constantly work overtime to process huge amounts of patient data. As a consequence, the error rate is high.


Alibaba Health unveiled this week its first artificial intelligence service for disease diagnosis, offering hope that advanced technology will alleviate the workload of mainland Chinese physicians in a nation suffering from an acute shortage of doctors.

The AI solution, called Doctor You, can be used for medical image diagnosis of CT scans to identify inflammatory cells in human organs, which can be an early indicator of cancer.

Continue reading “Alibaba, Tencent see AI as solution to China’s acute shortage of doctors” »

Jul 5, 2017

Treating Diabetes

Posted by in categories: biotech/medical, health

A new approach to treating diabetes sees gene therapy altering other cells in the pancreas so they produce insulin to replace the beta cells that are attacked by the immune system.


Progress has been made towards a potential solution to type 1 diabetes. The novel approach seeks to cure type 1 diabetes and to allow type 2 diabetics to stop using insulin shots by altering other cells in the pancreas so they produce insulin.

The research team based at UT Health San Antonio have found a way to increase the types of pancreatic cells that secrete insulin. The team are now moving towards starting clinical trials in the next three year but they are first testing the approach in larger sized animals, these studies are believed to cost an estimated $5 million.

Continue reading “Treating Diabetes” »

Jul 5, 2017

Revita Life Sciences Continues to Advance Multi-Modality Protocol in Attempt to Revive Brain Dead Subjects

Posted by in categories: bioengineering, biotech/medical, cryonics, futurism, genetics, health, life extension, neuroscience, posthumanism

Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational regenerative therapeutic applications, has announced that it is continuing to advance their novel, multi-modality clinical intervention in the state of brain death in humans.

“We have proactively continued to advance our multi-modality protocol, as an extended treatment before extubation, in an attempt to reverse the state of brain death” said Mr.Pranjal Agrawal, CEO Revita Life Sciences. “This treatment approach has yielded some very encouraging initial outcome signs, ranging from minor observations on blood pressure changes with response to painful stimuli, to eye opening and finger movements, with corresponding transient to permanent reversal changes in EEG patterns.”

Continue reading “Revita Life Sciences Continues to Advance Multi-Modality Protocol in Attempt to Revive Brain Dead Subjects” »

Jul 3, 2017

Researchers Produce World’s First Probiotic Beer

Posted by in categories: biotech/medical, health

As if anyone needed any excuse to drink more beer, a team of researchers have managed to produce an alcoholic beverage that also contains probiotics. In a novel breakthrough, they claim that the beer could help improve gut health and immunity, though the science is still out on that last one.

There are plenty of dairy-based probiotics, but currently there are no beers that also contain probiotics, mainly because beer contains something known as hop acids, which limit the growth and survival of potential probiotics. This spurred the researchers at the National University of Singapore to see if they could manage it.

They succeeded in developing a sour beer that can support the probiotic strain known as Lactobacillus paracasei L26. This particular probiotic is already found in the human gut, and there is some evidence that it might be able to regulate the immune system.

Continue reading “Researchers Produce World’s First Probiotic Beer” »

Jun 29, 2017

Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement

Posted by in categories: aging, bioengineering, biotech/medical, disruptive technology, DNA, genetics, health, life extension, posthumanism, science

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.

“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

Continue reading “Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement” »